Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048, (S0264410X2400330X), (10.1016/j.vaccine.2024.03.043)]

Anna Schultze*, Ivonne Martin, Davide Messina, Sophie Bots, Svetlana Belitser, Juan José Carreras-Martínez, Elisa Correcher-Martinez, Arantxa Urchueguía-Fornes, Mar Martín-Pérez, Patricia García-Poza, Felipe Villalobos, Meritxell Pallejà-Millán, Carlo Alberto Bissacco, Elena Segundo, Patrick Souverein, Fabio Riefolo, Carlos E. Durán, Rosa Gini, Miriam Sturkenboom, Olaf KlungelIan Douglas

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The authors regret that an incorrect supplementary file, containing copies of the images in the main article, was accidentally attached to the original publication of the article. This has now been corrected. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number126438
Pages (from-to)126438
JournalVaccine
Volume44
Early online date13 Oct 2024
DOIs
Publication statusPublished - 12 Jan 2025

Bibliographical note

Publisher Copyright:
© 2024 The Author(s)

Funding

The research leading to these results was conducted as part of the activities of the EU PE&PV (Pharmacoepidemiology and Pharmacovigilance) Research Network which is a public academic partnership coordinated by the Utrecht University, The Netherlands. Scientific work for this project was coordinated by the University Medical Center Utrecht in collaboration with the Vaccine Monitoring Collaboration for Europe network (VAC4EU). The project has received support from the European Medicines Agency under the Framework service contract nr EMA/2018/23/PE. The content of this paper expresses the opinion of the authors and may not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency or one of its committees or working parties.

FundersFunder number
European Medicines AgencyEMA/2018/23/PE

    Fingerprint

    Dive into the research topics of 'Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048, (S0264410X2400330X), (10.1016/j.vaccine.2024.03.043)]'. Together they form a unique fingerprint.

    Cite this